Diversity and Inclusion in U.S. Clinical Trial Recruitment: FDA and NIH Expectations
Diversity and Inclusion in U.S. Clinical Trial Recruitment: FDA and NIH Expectations Advancing Diversity and Inclusion in U.S. Clinical Trials: Regulatory Guidance and Recruitment Strategies Introduction Ensuring diversity and inclusion in U.S. clinical trial recruitment is critical for generating data that reflect the real-world patient population. Historically, women, racial and ethnic minorities, elderly patients, and…
Read More “Diversity and Inclusion in U.S. Clinical Trial Recruitment: FDA and NIH Expectations” »